Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13304)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 7, 2019 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou D, Fan JG. Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(17): 2019-2028 [PMID: 31114130 DOI: 10.3748/wjg.v25.i17.2019] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i17/2019.htm |
| Number | Citing Articles |
| 1 |
Vuong Vu, Karthika Muthuramalingam, Vineet Singh, Changlim Hyun, Young Mee Kim, Tatsuya Unno, Moonjae Cho. Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice. European Journal of Nutrition 2022; 61(2): 793 doi: 10.1007/s00394-021-02668-z
|
| 2 |
Maria Florian, Bai Li, Dominique Patry, Jocelyn Truong, Don Caldwell, Melanie C. Coughlan, Robert Woodworth, Jin Yan, Qixuan Chen, Ivan Petrov, Laziyan Mahemuti, Michelle Lalande, Nanqin Li, Laurie H. M. Chan, William G. Willmore, Xiaolei Jin. Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study. Cardiovascular Toxicology 2022; 22(6): 558 doi: 10.1007/s12012-022-09738-6
|
| 3 |
Clémence Rives, Anne Fougerat, Sandrine Ellero-Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet-Payrastre, Walter Wahli. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020; 10(12): 1702 doi: 10.3390/biom10121702
|
| 4 |
N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets. Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease. Terapevticheskii arkhiv 2020; 92(8): 29 doi: 10.26442/00403660.2020.08.000764
|
| 5 |
Jing Ji, Jiahong Sun, Juan Li, Jintang Xie, Bo Xi, Min Zhao. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children. Clinical Nutrition 2024; 43(1): 187 doi: 10.1016/j.clnu.2023.11.001
|
| 6 |
James Frampton, Kevin G. Murphy, Gary Frost, Edward S. Chambers. Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nature Metabolism 2020; 2(9): 840 doi: 10.1038/s42255-020-0188-7
|
| 7 |
Yangjie Li, Danping Liu, Yanglan He, Zeming Zhang, Ajuan Zeng, Chunlei Fan, Lingna Lyu, Zilong He, Huiguo Ding. The signatures and crosstalk of gut microbiome, mycobiome, and metabolites in decompensated cirrhotic patients. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1443182
|
| 8 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
| 9 |
Young-Seob Lee, Seon Min Oh, Qian-Qian Li, Kwan-Woo Kim, Dahye Yoon, Min-Ho Lee, Dong-Yeul Kwon, Ok-Hwa Kang, Dae Young Lee. Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease. Current Issues in Molecular Biology 2022; 44(1): 409 doi: 10.3390/cimb44010029
|
| 10 |
Keungmo Yang, Myeongjun Song. New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk. Nutrients 2023; 15(18): 3970 doi: 10.3390/nu15183970
|
| 11 |
Yu-Wen Chao, Yu-Tang Tung, Suh-Ching Yang, Hitoshi Shirakawa, Li-Han Su, Pei-Yu Loe, Wan-Chun Chiu. The Effects of Rice Bran on Neuroinflammation and Gut Microbiota in Ovariectomized Mice Fed a Drink with Fructose. Nutrients 2024; 16(17): 2980 doi: 10.3390/nu16172980
|
| 12 |
Ching-Chung Tsai, Min-Hsi Chiu, Ho-Poh Kek, Ming-Chun Yang, Yu-Tsun Su, Hsien-Kuan Liu, Ming-Shiang Wu, Yao-Tsung Yeh. The Reduced Gut Lachnospira Species Is Linked to Liver Enzyme Elevation and Insulin Resistance in Pediatric Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(7): 3640 doi: 10.3390/ijms25073640
|
| 13 |
Linwensi Zhu, Na Ying, Liuyi Hao, Ai Fu, Qinchao Ding, Feiwei Cao, Daxi Ren, Qiang Han, Songtao Li. Probiotic yogurt regulates gut microbiota homeostasis and alleviates hepatic steatosis and liver injury induced by high‐fat diet in golden hamsters. Food Science & Nutrition 2024; 12(4): 2488 doi: 10.1002/fsn3.3930
|
| 14 |
Anja Baumann, Cheng Jin, Annette Brandt, Cathrin Sellmann, Anika Nier, Markus Burkard, Sascha Venturelli, Ina Bergheim. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Nutrients 2020; 12(4): 951 doi: 10.3390/nu12040951
|
| 15 |
Li Qian, Shanshan Tian, Su Jiang, Yunping Tang, Tao Han. DHA-enriched phosphatidylcholine from Clupea harengus roes regulates the gut–liver axis to ameliorate high-fat diet-induced non-alcoholic fatty liver disease. Food & Function 2022; 13(22): 11555 doi: 10.1039/D2FO02672D
|
| 16 |
N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets, E. V. Chebanenko. Decision support system for predicting metabolic risks in patients with comorbid non-alcoholic fatty liver disease and gallstone disease after cholecystectomy. Medical alphabet 2020; 1(30): 11 doi: 10.33667/2078-5631-2020-30-11-17
|
| 17 |
Ramzi Hassouneh, Jasmohan S. Bajaj. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment. Journal of Clinical Medicine 2021; 10(2): 330 doi: 10.3390/jcm10020330
|
| 18 |
Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang. Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. Nutrients 2021; 13(3): 1013 doi: 10.3390/nu13031013
|
| 19 |
Di-Wei Zheng, Ke-Wei Chen, Jian-Hua Yan, Zhi-Yong Rao, Chi-Hui Yang, Rui-Lin Li, Ying Tang, Han Cheng, Xian-Zheng Zhang. A seed-like hydrogel with metabolic cascade microbiota for oral treatment of liver failure. Materials Today 2022; 58: 30 doi: 10.1016/j.mattod.2022.07.014
|
| 20 |
Congwei Gu, Zihan Zhou, Zehui Yu, Manli He, Lvqin He, Zhengzhong Luo, Wudian Xiao, Qian Yang, Fangfang Zhao, Weiyao Li, Liuhong Shen, Jianhong Han, Suizhong Cao, Zhicai Zuo, Junliang Deng, Qigui Yan, Zhihua Ren, Mingde Zhao, Shumin Yu. The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.870785
|
| 21 |
Hui Jiang, Tangyou Mao, Zhongmei Sun, Lei Shi, Xiao Han, Yang Zhang, Xiaosi Zhang, Jiali Wang, Juncong Hu, Liming Zhang, Junxiang Li, Haixiao Han. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1001778
|
| 22 |
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan. Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try. Clinical and Molecular Hepatology 2021; 27(1): 83 doi: 10.3350/cmh.2020.0298
|
| 23 |
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696
|
| 24 |
Xueying Lai, Hong Zhou, Yu Wan, Jiesi Kuang, Yuhui Yang, Limei Mai, Yumei Chen, Bin Liu. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier. International Immunopharmacology 2024; 128: 111429 doi: 10.1016/j.intimp.2023.111429
|
| 25 |
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
|
| 26 |
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
|
| 27 |
Ratika Sehgal, Mariana Ilha, Maija Vaittinen, Dorota Kaminska, Ville Männistö, Vesa Kärjä, Marjo Tuomainen, Kati Hanhineva, Stefano Romeo, Päivi Pajukanta, Jussi Pihlajamäki, Vanessa D. de Mello. Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. Nutrients 2021; 13(10): 3509 doi: 10.3390/nu13103509
|
| 28 |
Chao-Ran Bi, Jia-Tong Sun, Jian Du, Li-Yuan Chu, Yi-Jing Li, Xiao-Yu Jia, Yuan Liu, Wen-Ping Zhang, Yu-Chun Li, Yan-Jing Liu. Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet. Frontiers in Cellular and Infection Microbiology 2023; 12 doi: 10.3389/fcimb.2022.1005318
|
| 29 |
Junsang Oh, Jayoung Kim, Sanghak Lee, Gyubin Park, Kei-Anne Garcia Baritugo, Ki Jun Han, Sangheun Lee, Gi-Ho Sung. 1H NMR Serum Metabolomic Change of Trimethylamine N-oxide (TMAO) Is Associated with Alcoholic Liver Disease Progression. Metabolites 2024; 14(1): 39 doi: 10.3390/metabo14010039
|
| 30 |
Yajie Fu, Yanzhi Zhou, Linhu Shen, Xuewen Li, Haorui Zhang, Yeqi Cui, Ke Zhang, Weiguo Li, Wei-dong Chen, Shizhen Zhao, Yunfu Li, Wenling Ye. Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.973366
|
| 31 |
Bernardo Petriz, Jeeser Alves Almeida, Filipe Moura Ribeiro, Octávio Luiz Franco. Comprehensive Gut Microbiota. 2022; : 308 doi: 10.1016/B978-0-12-819265-8.00066-8
|
| 32 |
T.S. Sall, E.S. Shcherbakova, S.I. Sitkin, T.Ya. Vakhitov, I.G. Bakulin, E.V. Demyanova. Molecular mechanisms of non-alcoholic fatty liver disease development. Profilakticheskaya meditsina 2021; 24(4): 120 doi: 10.17116/profmed202124041120
|
| 33 |
Yiming Ni, Mengna Lu, Yuan Xu, Qixue Wang, Xinyi Gu, Ying Li, Tongxi Zhuang, Chenyi Xia, Ting Zhang, Xiao-jun Gou, Mingmei Zhou. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.908011
|
| 34 |
Wangxin Liu, Xianliang Luo, Jun Tang, Qiufen Mo, Hao Zhong, Hui Zhang, Fengqin Feng. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. European Journal of Nutrition 2021; 60(5): 2317 doi: 10.1007/s00394-020-02431-w
|
| 35 |
Jeong Seok Yu, Gi Soo Youn, Jieun Choi, Chang‐Ho Kim, Byung Yong Kim, Seung‐Jo Yang, Je Hee Lee, Tae‐Sik Park, Byoung Kook Kim, Yeon Bee Kim, Seong Woon Roh, Byeong Hyun Min, Hee Jin Park, Sang Jun Yoon, Na Young Lee, Ye Rin Choi, Hyeong Seob Kim, Haripriya Gupta, Hotaik Sung, Sang Hak Han, Ki Tae Suk, Do Yup Lee. Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease. Clinical and Translational Medicine 2021; 11(12) doi: 10.1002/ctm2.634
|
| 36 |
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Sergio Castorina, Stefano Puleo, Martina Barchitta, Antonella Agodi, Luisa Gallo, Gaetano La Greca, Saverio Latteri. Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database. Biology 2023; 12(5): 662 doi: 10.3390/biology12050662
|
| 37 |
Dan Zhang, Yong-Ping Jian, Yu-Ning Zhang, Yao Li, Li-Ting Gu, Hui-Hui Sun, Ming-Di Liu, Hong-Lan Zhou, Yi-Shu Wang, Zhi-Xiang Xu. Short-chain fatty acids in diseases. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01219-9
|
| 38 |
Angeliki Katsarou, Ioannis I Moustakas, Iryna Pyrina, Panagiotis Lembessis, Michael Koutsilieris, Antonios Chatzigeorgiou. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(17): 1993-2011 doi: 10.3748/wjg.v26.i17.1993
|
| 39 |
Cosmas Rinaldi A. Lesmana, Meudia Syahidah, Irsan Hasan, Rino A. Gan. The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease. European Medical Journal 2019; doi: 10.33590/emj/10310251
|
| 40 |
Charlotte Teunis, Max Nieuwdorp, Nordin Hanssen. Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites 2022; 12(6): 514 doi: 10.3390/metabo12060514
|
| 41 |
Hui Xiang, Dating Sun, Xin Liu, Zhi-Gang She, Yonghong Chen. The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.812610
|
| 42 |
Ikuko Kato, Jun Sun. Microbiome and Diet in Colon Cancer Development and Treatment. The Cancer Journal 2023; 29(2): 89 doi: 10.1097/PPO.0000000000000649
|
| 43 |
Bo Ren, Jun Hua, Chunyue Zhang, Yanmin Zhang, Yan Wang, Liyan Liu.
Expression and Significance of the Circular RNA circ_0001438 in the Development of Gastric Cancer
. Journal of Environmental Pathology, Toxicology and Oncology 2025; 44(1): 21 doi: 10.1615/JEnvironPatholToxicolOncol.2024053645
|
| 44 |
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. The Journal of Nutritional Biochemistry 2020; 85: 108478 doi: 10.1016/j.jnutbio.2020.108478
|
| 45 |
T. S. Krolevets, M. A. Livzan, M. I. Syrovenko. The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease. Meditsinskiy sovet = Medical Council 2024; (8): 50 doi: 10.21518/ms2024-009
|
| 46 |
Iris Pinheiro. A Comprehensive Guide to Nonalcoholic Fatty Liver Disease [Working Title]. 2024; doi: 10.5772/intechopen.1007741
|
| 47 |
Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
|
| 48 |
T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy. The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(5): 42 doi: 10.22416/1382-4376-2020-30-5-42-48
|
| 49 |
Seon Ju Mun, Jaeseo Lee, Kyung-Sook Chung, Mi-Young Son, Myung Jin Son. Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids. Cells 2021; 10(1): 126 doi: 10.3390/cells10010126
|
| 50 |
Aslı Yiğit, Gülhan Samur. Mechanisms behind the Role of SIBO in Non-Alcoholic Fatty Liver
Disease: An Interplay between Liver, Gut Microbiota and Nutrition. Current Nutrition & Food Science 2023; 19(2): 84 doi: 10.2174/1573401318666220520100202
|
| 51 |
Flavia Noelia Mazzini, Frank Cook, John Gounarides, Sebastián Marciano, Leila Haddad, Ana Jesica Tamaroff, Paola Casciato, Adrián Narvaez, María Florencia Mascardi, Margarita Anders, Federico Orozco, Nicolás Quiróz, Marcelo Risk, Susana Gutt, Adrián Gadano, Celia Méndez García, Martin L. Marro, Alberto Penas-Steinhardt, Julieta Trinks. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics 2021; 17(7) doi: 10.1007/s11306-021-01810-6
|
| 52 |
Moris Sangineto, Christoph Grander, Felix Grabherr, Lisa Mayr, Barbara Enrich, Julian Schwärzler, Marcello Dallio, Vidyasagar Naik Bukke, Archana Moola, Antonio Moschetta, Timon E. Adolph, Carlo Sabbà, Gaetano Serviddio, Herbert Tilg.
Recovery of
Bacteroides thetaiotaomicron
ameliorates hepatic steatosis in experimental alcohol-related liver disease
. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2089006
|
| 53 |
Antonio Gil-Gómez, Paola Brescia, Maria Rescigno, Manuel Romero-Gómez. Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. Seminars in Liver Disease 2021; 41(02): 191 doi: 10.1055/s-0041-1723752
|
| 54 |
Putra Santoso, Rita Maliza, Qonitah Fadhilah, Siti Jamalul Insani. Beneficial Effect of Pachyrhizus erosus Fiber as a Supplemental Diet to Counteract High Sugar-Induced Fatty Liver Disease in Mice. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2019; 26(4): 353 doi: 10.2478/rjdnmd-2019-0038
|
| 55 |
Tracey Hurrell, Jerolen Naidoo, Janine Scholefield. Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.864725
|
| 56 |
Shu-Cheng Huang, Yan-Feng He, Pan Chen, Kai-Li Liu, Aftab Shaukat. Gut microbiota as a target in the bone health of livestock and poultry: roles of short-chain fatty acids. Animal Diseases 2023; 3(1) doi: 10.1186/s44149-023-00089-5
|
| 57 |
Tianqi Cai, Xinhua Song, Xiaoxue Xu, Ling Dong, Shufei Liang, Meiling Xin, Yuhong Huang, Linghui Zhu, Tianxing Li, Xueke Wang, Yini Fang, Zhengbao Xu, Chao Wang, Meng Wang, Jingda Li, Yanfei Zheng, Wenlong Sun, Lingru Li. Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1323261
|
| 58 |
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
|
| 59 |
Xinlu Cao, Oksana Zolnikova, Roman Maslennikov, Maria Reshetova, Elena Poluektova, Arina Bogacheva, Maria Zharkova, Vladimir Ivashkin. Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease. Gastrointestinal Disorders 2023; 5(4): 464 doi: 10.3390/gidisord5040038
|
| 60 |
Tindaro Bongiovanni, Marilyn Ong Li Yin, Liam M. Heaney. The Athlete and Gut Microbiome: Short-chain Fatty Acids as Potential Ergogenic Aids for Exercise and Training. International Journal of Sports Medicine 2021; 42(13): 1143 doi: 10.1055/a-1524-2095
|
| 61 |
Sonia Facchin, Luisa Bertin, Erica Bonazzi, Greta Lorenzon, Caterina De Barba, Brigida Barberio, Fabiana Zingone, Daria Maniero, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Edoardo Vincenzo Savarino. Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. Life 2024; 14(5): 559 doi: 10.3390/life14050559
|
| 62 |
Prasun Kumar, Jin‐Hyung Lee, Jintae Lee. Diverse roles of microbial indole compounds in eukaryotic systems. Biological Reviews 2021; 96(6): 2522 doi: 10.1111/brv.12765
|
| 63 |
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5462063
|
| 64 |
Erika Pambianchi, Alessandra Pecorelli, Giuseppe Valacchi. Gastrointestinal tissue as a “new” target of pollution exposure. IUBMB Life 2022; 74(1): 62 doi: 10.1002/iub.2530
|
| 65 |
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep A. Tur, Cristina Bouzas. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients 2023; 15(18): 3987 doi: 10.3390/nu15183987
|
| 66 |
Yujuan Yu, Fumao Zeng, Peiheng Han, Li Zhang, Ling Yang, Feng Zhou, Qing Liu, Zheng Ruan. Dietary chlorogenic acid alleviates high-fat diet-induced steatotic liver disease by regulating metabolites and gut microbiota. International Journal of Food Sciences and Nutrition 2024; 75(4): 369 doi: 10.1080/09637486.2024.2318590
|